Caption Management, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,063,800
+208.5%
195,000
+254.5%
0.06%
+158.3%
Q2 2023$1,317,250
-10.8%
55,000
-38.9%
0.02%
+20.0%
Q3 2022$1,476,000
-69.7%
90,000
-74.0%
0.02%
-70.1%
Q2 2022$4,878,000
-37.9%
346,166
+6.8%
0.07%
-28.7%
Q1 2022$7,850,000
+2.0%
324,100
-1.7%
0.09%
+9.3%
Q4 2021$7,697,000
+2056.0%
329,700
+1433.5%
0.09%
+2050.0%
Q3 2021$357,000
-80.6%
21,500
-71.4%
0.00%
-83.3%
Q2 2021$1,836,000
-80.4%
75,300
-79.2%
0.02%
-88.1%
Q1 2021$9,356,000
-0.4%
362,700
+106.3%
0.20%
-6.5%
Q4 2020$9,398,000
+152.6%
175,800
+94.9%
0.22%
+147.1%
Q3 2020$3,721,000
-27.3%
90,200
-14.6%
0.09%
-48.8%
Q2 2020$5,121,000
+8.1%
105,657
-4.6%
0.17%
+6.9%
Q4 2019$4,737,000
+38.7%
110,700
+16.5%
0.16%
-10.7%
Q3 2019$3,416,000
-0.1%
95,000
-25.7%
0.18%
+3.5%
Q2 2019$3,420,000
+81.9%
127,900
+82.7%
0.17%
+65.4%
Q1 2019$1,880,000
+242.4%
70,000
+94.4%
0.10%
+141.9%
Q2 2018$549,00036,0000.04%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 28,439,114$590,396,0003.89%
GREAT POINT PARTNERS LLC 1,196,098$24,831,0003.87%
EMORY UNIVERSITY 196,601$4,081,0002.67%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
NEXTHERA CAPITAL LP 500,000$10,380,0001.99%
Palo Alto Investors LP 1,684,180$34,964,0001.41%
Opus Point Partners Management, LLC 20,828$432,0001.03%
Opaleye Management Inc. 195,000$4,048,0001.03%
GARRISON BRADFORD & ASSOCIATES INC 48,500$1,007,0000.81%
View complete list of ACADIA PHARMACEUTICALS INC shareholders